Skip to main content
. 2021 Sep 29;18(19):10248. doi: 10.3390/ijerph181910248

Figure 5.

Figure 5

Data sorted by the percentage of anxiety disorders (HADS-A3 / HADS-A1) in particular subgroups of risk modifying factors that were statistically significant (the significance level for the effect of psychostimulants is p < 0.05; for other factors p < 0.01).